Literature DB >> 25660064

Regulation of valve endothelial cell vasculogenic network architectures with ROCK and Rac inhibitors.

C Alexander Arevalos1, Amanda T Walborn1, Amanda A Rupert1, Jonathan M Berg1, Elizabeth L Godfrey1, Jacqueline M V Nguyen1, K Jane Grande-Allen2.   

Abstract

OBJECTIVE: The age- and disease-dependent presence of microvessels within heart valves is an understudied characteristic of these tissues. Neovascularization involves endothelial cell (EC) migration and cytoskeletal reorientation, which are heavily regulated by the Rho family of GTPases. Given that valve ECs demonstrate unique mesenchymal transdifferentiation and cytoskeletal mechanoresponsiveness, compared to vascular ECs, this study quantified the effect of inhibiting two members of the Rho family on vasculogenic network formation by valve ECs. APPROACH AND
RESULTS: A tubule-like structure vasculogenesis assay (assessing lacunarity, junction density, and vessel density) was performed with porcine aortic valve ECs treated with small molecule inhibitors of Rho-associated serine-threonine protein kinase (ROCK), Y-27632, or the Rac1 inhibitor, NSC-23766. Actin coordination, cell number, and cell migration were assessed through immunocytochemistry, MTT assay, and scratch wound healing assay. ROCK inhibition reduced network lacunarity and interrupted proper cell-cell adhesion and actin coordination. Rac1 inhibition increased lacunarity and delayed actin-mediated network formation. ROCK inhibition alone significantly inhibited migration, whereas both ROCK and Rac1 inhibition significantly reduced cell number over time compared to controls. Compared to a vascular EC line, the valve ECs generated a network with larger total vessel length, but a less smooth appearance.
CONCLUSIONS: Both ROCK and Rac1 inhibition interfered with key processes in vascular network formation by valve ECs. This is the first report of manipulation of valve EC vasculogenic organization in response to small molecule inhibitors. Further study is warranted to comprehend this facet of valvular cell biology and pathology and how it differs from vascular biology.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic valve; Rac1; Rho kinase; Valve endothelial cell; Vasculogenesis

Mesh:

Substances:

Year:  2015        PMID: 25660064      PMCID: PMC4974942          DOI: 10.1016/j.mvr.2015.01.008

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  72 in total

Review 1.  Endothelial cell migration during angiogenesis.

Authors:  Laurent Lamalice; Fabrice Le Boeuf; Jacques Huot
Journal:  Circ Res       Date:  2007-03-30       Impact factor: 17.367

2.  Age-related changes in aortic valve hemostatic protein regulation.

Authors:  Liezl R Balaoing; Allison D Post; Huiwen Liu; Kyung Taeck Minn; K Jane Grande-Allen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-31       Impact factor: 8.311

3.  Rho kinases regulate endothelial invasion and migration during valvuloseptal endocardial cushion tissue formation.

Authors:  Masahide Sakabe; Kazuo Ikeda; Kazuki Nakatani; Norifumi Kawada; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Toshiyuki Yamagishi; Yuji Nakajima
Journal:  Dev Dyn       Date:  2006-01       Impact factor: 3.780

4.  A 3D microfluidic platform incorporating methacrylated gelatin hydrogels to study physiological cardiovascular cell-cell interactions.

Authors:  Michelle B Chen; Suthan Srigunapalan; Aaron R Wheeler; Craig A Simmons
Journal:  Lab Chip       Date:  2013-03-25       Impact factor: 6.799

5.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.

Authors:  T Ishizaki; M Uehata; I Tamechika; J Keel; K Nonomura; M Maekawa; S Narumiya
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

6.  Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation.

Authors:  Xiaoxiao Gu; Kristyn S Masters
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-03       Impact factor: 4.733

7.  Distribution of SPARC during neovascularisation of degenerative aortic stenosis.

Authors:  A Charest; A Pépin; R Shetty; C Côté; P Voisine; F Dagenais; P Pibarot; P Mathieu
Journal:  Heart       Date:  2006-05-18       Impact factor: 5.994

8.  Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve.

Authors:  Fariba Chalajour; Hendrik Treede; Ursula M Gehling; Alireza Ebrahimnejad; Dieter H Boehm; Robert K Riemer; Suleyman Ergun; Hermann Reichenspurner
Journal:  Exp Cell Res       Date:  2007-03-14       Impact factor: 3.905

9.  Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function.

Authors:  Julie A Benton; Cole A DeForest; Vani Vivekanandan; Kristi S Anseth
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

10.  A three-dimensional co-culture model of the aortic valve using magnetic levitation.

Authors:  Hubert Tseng; Liezl R Balaoing; Bagrat Grigoryan; Robert M Raphael; T C Killian; Glauco R Souza; K Jane Grande-Allen
Journal:  Acta Biomater       Date:  2013-09-11       Impact factor: 8.947

View more
  1 in total

1.  Valve Interstitial Cells Act in a Pericyte Manner Promoting Angiogensis and Invasion by Valve Endothelial Cells.

Authors:  C Alexander Arevalos; Jonathan M Berg; Jacqueline M V Nguyen; Elizabeth L Godfrey; Claudia Iriondo; K Jane Grande-Allen
Journal:  Ann Biomed Eng       Date:  2016-02-23       Impact factor: 3.934

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.